RenovoRx, Inc. (RNXT)
NASDAQ·Healthcare·Biotechnology
$0.85
-2.88%
Mkt Cap $29.33M
Next Earnings
In 22 daysThu, May 21, 2026
EPS Estimate
-$0.08
1 analysts
Revenue Estimate
$469.50K
Last quarter: beat by +0.00% on EPS, -43.29% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$29.33M
P/E
—
Fwd P/E
1.93
P/S
26.25
Rev TTM
—
EPS TTM
-$0.32